EX-10.2 3 mygn-ex102_187.htm EX-10.2

Exhibit 10.2

Attachment

Each of the following directors and executive officers of Myriad Genetics, Inc. has entered into the Company’s standard form Indemnification Agreement.

Directors and Executive Officer | Execution Date
John T. Henderson, M.D., Chairman of the Board | June 02, 2009
Walter Gilbert, Ph.D., Vice Chairman of the Board | June 02, 2009
Lawrence C. Best, Director | September 16, 2009
Heiner Dreismann, Ph.D., Director | September 16, 2010
Dennis H. Langer, M.D., J.D., Director | June 02, 2009
S. Louise Phanstiel, Director | September 16, 2009
Mark C. Capone, President and Chief Executive Officer | June 16, 2009
Alexander Ford, President, Myriad Genetic Laboratories, Inc. | July 01, 2015
Gary A. King, EVP International Operations | June 13, 2013
Jerry S. Lanchbury, Ph.D., Chief Scientific Officer | June 16, 2009
Richard M. Marsh, Esq., EVP, General Counsel and Secretary | June 16, 2009
Ralph L. McDade, President, Myriad RBM, Inc. | June 05, 2014
R. Bryan Riggsbee, Chief Financial Officer and Treasurer | February 23, 2015
Bernard F. Tobin, President, Crescendo Biosciences, Inc. | February 23, 2015
Mark Verratti, President, Assurex Health, Inc. | September 19, 2017